Immutep (IMMP) Short Interest Ratio & Short Volume → This Wall Street stock prediction just went viral (From Chaikin Analytics) (Ad) Free IMMP Stock Alerts $2.82 -0.11 (-3.75%) (As of 05/15/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Immutep Short Interest DataCurrent Short Volume2,690,000 sharesPrevious Short Volume1,460,000 sharesChange Vs. Previous Month+84.25%Dollar Volume Sold Short$7.24 millionShort Interest Ratio / Days to Cover13.1Last Record DateApril 30, 2024Outstanding Shares87,930,000 sharesPercentage of Shares Shorted3.06%Today's Trading Volume260,887 sharesAverage Trading Volume184,046 sharesToday's Volume Vs. Average142% Short Selling Immutep ? Sign up to receive the latest short interest report for Immutep and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatIMMP Short Interest Over TimeIMMP Days to Cover Over TimeIMMP Percentage of Float Shorted Over Time Ad Chaikin AnalyticsWall Street legend who predicted 2021 tech crash issues new warningPeople around the world follow 50-year Wall Street veteran Marc Chaikin for his surprisingly accurate stock predictions. And he just issued an urgent WARNING for some of the most popular stocks in U.S. history.Watch his stock warning right here, 100% free of charge Immutep Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20242,690,000 shares $7.24 million +84.3%N/A13.1 $2.69 4/15/20241,460,000 shares $3.37 million +15.9%N/A9.2 $2.31 3/31/20241,260,000 shares $2.94 million +10.5%N/A8.9 $2.33 3/15/20241,140,000 shares $2.72 million +5.6%N/A8.7 $2.39 2/29/20241,080,000 shares $2.53 million -0.9%N/A6.8 $2.34 2/15/20241,090,000 shares $2.51 million +25.3%N/A8 $2.30 Get the Latest News and Ratings for IMMP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Immutep and its competitors with MarketBeat's FREE daily newsletter. 1/31/2024869,600 shares $1.89 million +53.4%N/A6.1 $2.17 1/15/2024566,800 shares $1.46 million +4.9%N/A3.2 $2.58 12/31/2023540,200 shares $1.30 million +51.4%N/A3 $2.40 12/15/2023356,700 shares $888,183.00 +3.5%N/A2.1 $2.49 11/30/2023344,700 shares $685,953.00 -8.1%N/A2.4 $1.99 11/15/2023375,200 shares $690,368.00 -7.1%N/A2.5 $1.84 10/31/2023403,900 shares $763,371.00 -11.9%N/A2.8 $1.89 10/15/2023458,300 shares $843,272.00 -3.5%N/A3 $1.84 9/30/2023474,800 shares $902,120.00 -2.1%N/A3.5 $1.90 9/15/2023485,200 shares $980,104.00 +2.0%N/A3 $2.02 8/31/2023475,600 shares $903,640.00 +10.9%N/A2.6 $1.90 8/15/2023428,800 shares $861,888.00 +12.5%N/A1.4 $2.01 7/31/2023381,100 shares $823,176.00 +29.6%N/A0.2 $2.16 7/15/2023294,000 shares $640,920.00 -40.0%N/A0.2 $2.18 6/30/2023490,300 shares $1.03 million -26.4%N/A0.3 $2.11 6/15/2023666,200 shares $1.42 million +1.9%N/A0.4 $2.13 5/31/2023653,800 shares $1.31 million -16.1%N/A0.4 $2.01 5/15/2023779,500 shares $1.20 million -0.4%N/A0.5 $1.54 4/30/2023782,600 shares $1.28 million -15.3%N/A9 $1.64 4/15/2023923,400 shares $1.47 million +16.4%N/A10.6 $1.59 3/31/2023793,500 shares $1.33 million -3.0%N/A10 $1.68 3/15/2023818,000 shares $1.42 million -0.6%N/A6 $1.73 2/28/2023822,900 shares $1.34 million +1.3%N/A5.6 $1.63 2/15/2023812,600 shares $1.44 million +5.0%N/A5 $1.77 1/31/2023773,800 shares $1.51 million +65.0%N/A4.4 $1.95 1/15/2023469,100 shares $942,891.00 +8.1%N/A2.7 $2.01 12/30/2022434,000 shares $759,500.00 +112.2%N/A2.6 $1.75 12/15/2022204,500 shares $384,460.00 +9.1%N/A1.3 $1.88 11/30/2022187,400 shares $449,760.00 -4.8%N/A2.1 $2.40 11/15/2022196,800 shares $429,024.00 +4.7%N/A2.7 $2.18 10/31/2022188,000 shares $336,520.00 -18.9%N/A2.8 $1.79 10/15/2022231,700 shares $443,705.50 +32.5%N/A4 $1.92 9/30/2022174,900 shares $272,844.00 +34.4%N/A3 $1.56 9/15/2022130,100 shares $243,287.00 -12.3%N/A2.3 $1.87Amazon's betting big on this unknown AI company (Ad)Amazon's Betting Big on This Unknown AI Company Amazon has just made a stunning $144 million investment in one small AI company.Discover why this company IMMP Short Interest - Frequently Asked Questions What is Immutep's current short interest? Short interest is the volume of Immutep shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 2,690,000 shares of IMMP short. Learn More on Immutep's current short interest. What is a good short interest ratio for Immutep? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. IMMP shares currently have a short interest ratio of 13.0. Learn More on Immutep's short interest ratio. Is Immutep's short interest increasing or decreasing? Immutep saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 2,690,000 shares, an increase of 84.2% from the previous total of 1,460,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Immutep's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Immutep: Akebia Therapeutics, Inc. (5.66%), Design Therapeutics, Inc. (9.06%), ESSA Pharma Inc. (2.09%), Emergent BioSolutions Inc. (14.13%), Aldeyra Therapeutics, Inc (4.03%), Pyxis Oncology, Inc. (3.95%), XBiotech Inc. (3.88%), Omeros Co. (24.41%), 2seventy bio, Inc. (14.59%), G1 Therapeutics, Inc. (5.41%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Immutep stock? Short selling IMMP is an investing strategy that aims to generate trading profit from Immutep as its price is falling. IMMP shares are trading down $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Immutep? A short squeeze for Immutep occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of IMMP, which in turn drives the price of the stock up even further. How often is Immutep's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IMMP, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Akebia Therapeutics Short Interest Design Therapeutics Short Interest ESSA Pharma Short Interest Emergent BioSolutions Short Interest Aldeyra Therapeutics Short Interest Pyxis Oncology Short Interest XBiotech Short Interest Omeros Short Interest 2seventy bio Short Interest G1 Therapeutics Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:IMMP) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersAmazon's betting big on this unknown AI companyManward PressWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingShocking $16T Elon Musk Crypto LeakCrypto 101 MediaDems have chosen Biden replacement?Paradigm PressGold Set to EXPLODE!Gold Safe ExchangeThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss Ratings"The Biggest Drug Ever" Is ComingBehind the Markets